Back to Search
Start Over
Mutation burden and other molecular markers of prognosis in colorectal cancer treated with curative intent: results from the QUASAR 2 clinical trial and an Australian community-based series
- Source :
- The Lancet Gastroenterology & Hepatology; September 2018, Vol. 3 Issue: 9 p635-643, 9p
- Publication Year :
- 2018
-
Abstract
- Molecular indicators of colorectal cancer prognosis have been assessed in several studies, but most analyses have been restricted to a handful of markers. We aimed to identify prognostic biomarkers for colorectal cancer by sequencing panels of multiple driver genes.
Details
- Language :
- English
- ISSN :
- 24681253
- Volume :
- 3
- Issue :
- 9
- Database :
- Supplemental Index
- Journal :
- The Lancet Gastroenterology & Hepatology
- Publication Type :
- Periodical
- Accession number :
- ejs46183173
- Full Text :
- https://doi.org/10.1016/S2468-1253(18)30117-1